Breaking News

Tweet TWEET

Quest Diagnostics Confirms Investor Day on November 16

            Quest Diagnostics Confirms Investor Day on November 16

PR Newswire

MADISON, N.J., Nov. 9, 2012

MADISON, N.J., Nov.9, 2012 /PRNewswire/ --As previously announced, Quest
Diagnostics Incorporated (NYSE: DGX), the world's leading provider of
diagnostic testing, information and services, will host an Investor Day on
Friday, November 16, 2012 at The Hudson Theatre at the Millennium Broadway
Times Square, 145 West 44^th Street, New York, NY.

During the event, Quest Diagnostics' new executive leadership team will
discuss the company's strategy, performance and plans to drive shareholder
value.

In Person Attendance
Advanced registration is required and attendance will be limited to those who
register in advance. To register for the meeting, please go to the following
website:
http://edge.media-server.com/m/go/registerquestdiagnostics. Check-in will
begin at 8:00 a.m. with a continental breakfast. Management presentations will
begin promptly at 9:00 a.m. and conclude at 12:30 p.m.

Webcast Attendance
A live webcast of the event will be broadcast simultaneously on the Investor
Relations page of the Quest Diagnostics website for all interested parties. To
access the webcast or a replay of the event, visit:
www.QuestDiagnostics.com/investor. The webcast will begin promptly at 9:00
a.m. and conclude at 12:30 p.m. A replay will be available following the
meeting.

Quest Diagnostics is the world's leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its network of laboratories and patient service
centers, and providesinterpretive consultation through its extensive medical
and scientific staff. Quest Diagnostics is a pioneer in developing innovative
diagnostic tests and advanced healthcare information technology solutions that
help improve patient care. Additional company information is available at
QuestDiagnostics.com.

Contacts:
Kathleen Valentine (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800

SOURCE Quest Diagnostics Incorporated

Website: http://www.questdiagnostics.com